You are here: Industry Insights > Insulin

News List

Cost-Related Insulin Underuse May Affect One in Four Patients drugs
December 04, 2018
About one in four patients report cost-related insulin underuse, which is associated with poor glycemic control, according to a research letter published online Dec. 3 in JAMA Internal Medicine.....
New Edition of China’s National Essential Drugs List Has Released! Xiaoyu
November 07, 2018
Types of Insulin and Oral Hypoglycemic Drug Increased by 150%, with Varieties being Newer and More Complete!
Insulin supply chain transparency needed to prevent price hikes europeanpharmaceuticalreview
November 05, 2018
The Endocrine Society has reported that increasing costs of insulin means that people are often deciding to forgo necessary treatment…
Minnesota AG targets Sanofi, Eli Lilly and Novo Nordisk in latest insulin pricing attack fiercepharma
October 19, 2018
Insulin makers have faced no shortage of scrutiny in recent years over escalating prices, and now Minnesota Attorney General Lori Swanson is the latest to file a legal salvo against Sanofi, Novo Nordisk and Eli Lilly for ...
Novo Nordisk stockpiles 16 weeks' worth of insulin in preparation for hard Brexit pharmafile
September 13, 2018
Danish multinational Novo Nordisk has announced that they are increasing their stocks of insulin products to ensure that there are 16 weeks’ worth of supplies, in preparation for a hard no deal Brexit.
DexCom acquires TypeZero Tech biospectrumasia
August 24, 2018
DexCom expects to launch the first automated insulin delivery system using TypeZero's InControl algorithm in 2019.
Beta-Cell function of diabetic patients unaffected by metformin with insulin biospectrumasia
June 27, 2018
Restoring Insulin Secretion (RISE) Pediatric Medication Study shows that youth have markedly reduced insulin sensitivity and respond differently to medications
Delivering insulin in a pill europeanpharmaceuticalreview
June 27, 2018
Technique could replace daily injections for diabetics…
French Insulin Maker Spurned by Eli Lilly Forges Deal with China’s Tonghua Dongbao biospace
April 27, 2018
Shares of Adocia are up nearly 30 percent this morning after the French company announced it granted exclusive development and commercialization rights of its insulin products to Tonghua Dongbao Pharmaceuticals
Oramed Initiates 90-Day Clinical Study for Oral Insulin americanpharmaceuticalreview
April 24, 2018
Oramed Pharmaceuticals has begun screening patients in its 90-day dose-ranging Pivotal Phase 2b HbA1c clinical study of its oral insulin capsule, ORMD-0801.

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page